14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Jan 28, 2022 $0.357 $0.360 $0.317 $0.321 1 593 900
Jan 27, 2022 $0.341 $0.398 $0.332 $0.361 4 280 500
Jan 26, 2022 $0.300 $0.403 $0.291 $0.332 9 366 100
Jan 25, 2022 $0.526 $0.549 $0.496 $0.530 856 500
Jan 24, 2022 $0.500 $0.550 $0.481 $0.530 1 678 500
Jan 21, 2022 $0.558 $0.576 $0.533 $0.550 1 183 000
Jan 20, 2022 $0.590 $0.595 $0.550 $0.552 688 100
Jan 19, 2022 $0.570 $0.600 $0.560 $0.597 863 900
Jan 18, 2022 $0.601 $0.616 $0.573 $0.580 459 300
Jan 14, 2022 $0.590 $0.623 $0.584 $0.619 361 400
Jan 13, 2022 $0.600 $0.608 $0.581 $0.594 684 900
Jan 12, 2022 $0.612 $0.627 $0.600 $0.602 460 200
Jan 11, 2022 $0.600 $0.625 $0.590 $0.619 532 300
Jan 10, 2022 $0.605 $0.610 $0.580 $0.594 789 100
Jan 07, 2022 $0.610 $0.657 $0.603 $0.610 949 100
Jan 06, 2022 $0.640 $0.650 $0.590 $0.620 1 071 600
Jan 05, 2022 $0.697 $0.697 $0.645 $0.652 760 630
Jan 04, 2022 $0.650 $0.698 $0.650 $0.683 620 852
Jan 03, 2022 $0.600 $0.660 $0.600 $0.650 1 105 810
Dec 31, 2021 $0.602 $0.628 $0.602 $0.603 1 321 226
Dec 30, 2021 $0.641 $0.660 $0.600 $0.613 2 493 666
Dec 29, 2021 $0.670 $0.680 $0.640 $0.669 1 598 868
Dec 28, 2021 $0.650 $0.690 $0.650 $0.680 1 047 714
Dec 27, 2021 $0.650 $0.690 $0.625 $0.660 1 694 252
Dec 23, 2021 $0.672 $0.700 $0.630 $0.655 1 665 475
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT